[email protected] & No phone number available.

Noah Loul

Former CEO at NFT Brands Inc. | Beverly Hills, California, United States

*50 free lookup(s) per month.

No credit card required.

Brent Passer’s Emails [email protected]

Brent Passer’s Phone Numbers No phone number available.

Social Media

Brent Passer’s Location Boston, Massachusetts, United States

Brent Passer’s Expertise ULTImate Y2H Discovery Solutions: Hybrigenics offers a fully comprehensive & optimized yeast two-hybrid (Y2H) screening service with a choice of 120+ libraries (35+ species) from Arabidopsis to Zebrafish: https://www.hybrigenics-services.com/library/1 ULTImate Y2H Discovery Solutions offerings: • Y2H: Screen proteins • MBmate: Screen Membrane-associated proteins • Y3H: Screen RNA • Y1H: Screen DNA • Y2H+1: Screen phosphorylated bait proteins • Y2H+Chem: Screen Protein/drug pairs (molecular glues) • YchemH: Screen small molecules (Target ID) Synthetic single-domain antibody services (https://www.hybribody.com) Advantages include: 1. Only 100-150 ug’s (>85% purity) of biotinylated antigen required for VHH selection 2. Antigens need not be immunogenic since VHH selection takes place in vitro (no immunizations) 3. A negative selection step may be performed prior to positive selection in order to remove unwanted VHH’s recognizing a related antigen 4. VHH’s can be selected against membrane-associated antigens by whole-cell biopanning, nanodiscs or proteoliposomes.

Brent Passer’s Current Industry Hybrigenics

Brent Passer’s Prior Industry
Hybrigenics

Not the Brent Passer you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Hybrigenics

Director, Business Development, US

Tue Jan 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Skills

Languages

FAQ About Brent Passer

Brent Passer is located at
Boston, Massachusetts, United States

Brent Passer is a
ULTImate Y2H Discovery Solutions: Hybrigenics offers a fully comprehensive & optimized yeast two-hybrid (Y2H) screening service with a choice of 120+ libraries (35+ species) from Arabidopsis to Zebrafish: https://www.hybrigenics-services.com/library/1 ULTImate Y2H Discovery Solutions offerings: • Y2H: Screen proteins • MBmate: Screen Membrane-associated proteins • Y3H: Screen RNA • Y1H: Screen DNA • Y2H+1: Screen phosphorylated bait proteins • Y2H+Chem: Screen Protein/drug pairs (molecular glues) • YchemH: Screen small molecules (Target ID) Synthetic single-domain antibody services (https://www.hybribody.com) Advantages include: 1. Only 100-150 ug’s (>85% purity) of biotinylated antigen required for VHH selection 2. Antigens need not be immunogenic since VHH selection takes place in vitro (no immunizations) 3. A negative selection step may be performed prior to positive selection in order to remove unwanted VHH’s recognizing a related antigen 4. VHH’s can be selected against membrane-associated antigens by whole-cell biopanning, nanodiscs or proteoliposomes. Hybrigenics

Brent Passer currently works in the
Hybrigenics

Brent Passer specializes in
ULTImate Y2H Discovery Solutions: Hybrigenics offers a fully comprehensive & optimized yeast two-hybrid (Y2H) screening service with a choice of 120+ libraries (35+ species) from Arabidopsis to Zebrafish: https://www.hybrigenics-services.com/library/1 ULTImate Y2H Discovery Solutions offerings: • Y2H: Screen proteins • MBmate: Screen Membrane-associated proteins • Y3H: Screen RNA • Y1H: Screen DNA • Y2H+1: Screen phosphorylated bait proteins • Y2H+Chem: Screen Protein/drug pairs (molecular glues) • YchemH: Screen small molecules (Target ID) Synthetic single-domain antibody services (https://www.hybribody.com) Advantages include: 1. Only 100-150 ug’s (>85% purity) of biotinylated antigen required for VHH selection 2. Antigens need not be immunogenic since VHH selection takes place in vitro (no immunizations) 3. A negative selection step may be performed prior to positive selection in order to remove unwanted VHH’s recognizing a related antigen 4. VHH’s can be selected against membrane-associated antigens by whole-cell biopanning, nanodiscs or proteoliposomes.